Baudax Bio

Malvern, United States

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

$1.9M raised

Aug 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Baudax Bio raised?

Baudax Bio has raised $1.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2023.

Who are Baudax Bio's investors?

Baudax Bio's investors include Marathon Asset Management.

Where is Baudax Bio headquartered?

Baudax Bio is headquartered in Malvern, United States.

What does Baudax Bio do?

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

What stage is Baudax Bio at?

Baudax Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 17, 2023.

MLA

"Baudax Bio — Funding & Investors." VCBacked, August 17, 2023, https://www.vcbacked.co/company/baudax-bio. Accessed July 3, 2026.

APA

VCBacked. (2023). Baudax Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/baudax-bio

Wikipedia (cite web)

{{cite web |title=Baudax Bio — Funding & Investors |url=https://www.vcbacked.co/company/baudax-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 17, 2023.